Keyword: InFLAMES

Academician and Director of InFLAMES Flagship Sirpa Jalkanen and Dr. Markku Jalkanen have been nominated for the European Inventor Award. They are finalists in the Small and medium enterprises category, where they are against two other European teams. They were selected from among more than 550 candidates in a competition organised by the European Patent Office (EPO). The winners of the European Inventor Award 2024 will be announced on 9 July 2024 in Malta.

The joint InFlames Research Flagship of the University of Turku and Åbo Akademi University received €6.5 million in continued funding from the Research Council of Finland for 2024–2026. It is the first instalment of the continued funding as the Research Council has announced that it is prepared to fund the Flagship with altogether €10.4 million by summer 2028.

Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the progression of type 1 diabetes.

This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity on 25–26 August 2023, with the title Sculpting tissues – Cells matrix and forces. Registration is open until Friday, 11 August 2023.

An international team of researchers has discovered how the so-called tertiary lymphoid-like structures can help the human immune defence to find cancer cells and destroy them. Researchers from the InFLAMES research flagship of the University of Turku, Finland, participated in the study and the research article was published in the esteemed Cancer Cell journal.

Researchers at Turku University and Åbo Akademi University, Finland, have identified that finger-like cellular extensions called filopodia contribute to building a barrier surrounding breast tumours.

The joint InFLAMES Flagship of the University of Turku and Åbo Akademi University has invited Professor Tero Aittokallio as a Visiting Professor. Aittokallio will give his first InFLAMES Visiting Professor Lecture on Monday October 28th.

The Hospital District of Southwest Finland has chosen the Turku Immunology Centre as its unit of excellence. The Centre, which was established at the end of 2021, was also selected to the Roadmap for Research Infrastructures of the University of Turku.

New discovery on the causes of PAP lung disease can also offer solutions for treating obesity and heart disease. The research group of Associate Professor Alexander Mildner at the University of Turku, Finland, identified a genetic defect that causes the accumulation of lipids in the pulmonary alveoli.  

The theme of this year’s BioCity Symposium, immunology, has sparked great interest. Over 400 people have registered for the Symposium that is organised on 25–26 August. The keynote speaker is Sir Peter Ratcliffe, the Nobel Prize Laureate in medicine 2019.